Avoiding kidney damage in ICU sedation with sevoflurane: use isoflurane instead
- PMID: 35331541
- DOI: 10.1016/j.bja.2022.02.031
Avoiding kidney damage in ICU sedation with sevoflurane: use isoflurane instead
Abstract
Intensive care unit (ICU) sedation with sevoflurane is associated with nephrogenic diabetes insipidus. Given that isoflurane is now licenced (in Europe) for ICU sedation and has Investigational New Drug status in the USA, evidence indicates that clinicians should stop using sevoflurane in this indication except in the context of clinical trials.
Keywords: acute kidney injury; diabetes insipidus; isoflurane; nephrotoxicity; sedation; sevoflurane.
Copyright © 2022 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declarations of interest The author is a consultant to Paion (Aachen, Germany) and Medtronic (Watford, UK).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
